Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
12:05pm, Sunday, 10'th Nov 2024
Conditions are getting a bit more challenging for the drugmaker.
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
05:45am, Sunday, 10'th Nov 2024
The good times aren't over, but the peak of the party might be passing.
2 unstoppable non-tech stocks set to join the $1 trillion club
12:45pm, Saturday, 09'th Nov 2024
Tesla (NASDAQ: TSLA) is the latest stock to reach the $1 trillion market capitalization status, as other equities show potential for joining this exclusive club.
The biopharmaceutical sector showed signs of recovery in the third quarter of 2024, fueled by increased investor optimism following the U.S. Federal Reserve's interest rate cuts in September.
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.
04:55am, Friday, 08'th Nov 2024
The market's perception of the pharmaceutical company has undeniably shifted.
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?
06:33pm, Wednesday, 06'th Nov 2024
Eli Lilly stock has fallen in the days following the release of its latest earnings numbers.
Should Investors Buy Weakness in These High-Growth Stocks?
11:16am, Tuesday, 05'th Nov 2024
The 2024 Q3 earnings season continues at a rapid pace, with a nice variety of companies delivering quarterly results daily.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Tuesday, 05'th Nov 2024
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
09:04am, Tuesday, 05'th Nov 2024
INDIANAPOLIS , Nov. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kina
Is Eli Lilly a Buy? Analyst Confidence Grows for 2025
08:31am, Tuesday, 05'th Nov 2024
Eli Lilly's NYSE: LLY market isn't out of the weeds yet but will rebound strongly in 2025. The Q3 results failed to spark a rally because of underperformance, but the salient details are that growth i
Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects
10:22am, Monday, 04'th Nov 2024
Explore Lilly's (LLY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
This Pharma Stock Is Soaring 21%. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.
06:27am, Monday, 04'th Nov 2024
Viking said that an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body weight in four weeks.
KFSHRC & Lilly Collaborate in Alzheimer's Early Detection
10:37am, Sunday, 03'rd Nov 2024
RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve Alzheimer's patient care. T
Analysts revise Eli Lilly stock price targets
09:54am, Sunday, 03'rd Nov 2024
Eli Lilly (NYSE: LLY), one of the U.S.'s foremost pharmaceutical giants, faced a sharp 8% drop in its stock price after reporting disappointing third-quarter results, erasing nearly $70 billion from i
Could This Near Trillion-Dollar Stock Be a Millionaire Maker?
09:45am, Sunday, 03'rd Nov 2024
Size means little in light of this company's prospects.
